Literature DB >> 16618735

Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells.

Tovit Rosenzweig1, Amotz Ziv-Av, Cunli Xiang, Wei Lu, Simona Cazacu, Dvir Taler, Cathie G Miller, Reuven Reich, Yigal Shoshan, Yair Anikster, Gila Kazimirsky, Ronit Sarid, Chaya Brodie.   

Abstract

In this study, we examined the expression and functions of related to testes-specific, vespid, and pathogenesis protein 1 (RTVP-1) in glioma cells. RTVP-1 was expressed in high levels in glioblastomas, whereas its expression in low-grade astrocytomas and normal brains was very low. Transfection of glioma cells with small interfering RNAs targeting RTVP-1 decreased cell proliferation in all the cell lines examined and induced cell apoptosis in some of them. Overexpression of RTVP-1 increased astrocyte and glioma cell proliferation and the anchorage-independent growth of the cells. In addition, overexpression of RTVP-1 rendered glioma cells more resistant to the apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand and serum deprivation. To delineate the molecular mechanisms involved in the survival effects of RTVP-1, we examined the expression and phosphorylation of various apoptosis-related proteins. We found that overexpression of RTVP-1 decreased the phosphorylation of c-Jun-NH2-kinase and increased the expression of Bcl2 and that the protective effect of RTVP-1 was partially mediated by Bcl2. Finally, we found that RTVP-1 regulated the invasion of glioma cells as was evident by their enhanced migration through Matrigel and by their increased invasion in a spheroid confrontation assay. The increased invasive potential of the RTVP-1 overexpressors was also shown by the increased activity of matrix metalloproteinase 2 in these cells. Our results suggest that the expression of RTVP-1 is correlated with the degree of malignancy of astrocytic tumors and that RTVP-1 is involved in the regulation of the growth, survival, and invasion of glioma cells. Collectively, these findings suggest that RTVP-1 is a potential therapeutic target in gliomas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16618735     DOI: 10.1158/0008-5472.CAN-05-2851

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  32 in total

1.  Structural studies of human glioma pathogenesis-related protein 1.

Authors:  Oluwatoyin A Asojo; Raymond A Koski; Nathalie Bonafé
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-09-08

2.  Expression, purification, crystallization and preliminary X-ray analysis of a truncated soluble domain of human glioma pathogenesis-related protein 1.

Authors:  Nathalie Bonafé; Bin Zhan; Maria Elena Bottazzi; Oriana A Perez; Raymond A Koski; Oluwatoyin A Asojo
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-10-28

3.  Immuno-proteomic analysis of Trichinella spiralis, T. pseudospiralis, and T. papuae extracts recognized by human T. spiralis-infected sera.

Authors:  Chalermchai Somboonpatarakun; Rutchanee Rodpai; Pewpan M Intapan; Oranuch Sanpool; Lakkhana Sadaow; Chaisiri Wongkham; Tonkla Insawang; Thidarut Boonmars; Wanchai Maleewong
Journal:  Parasitol Res       Date:  2017-11-30       Impact factor: 2.289

4.  Tracing the Evolutionary History of the CAP Superfamily of Proteins Using Amino Acid Sequence Homology and Conservation of Splice Sites.

Authors:  Anup Abraham; Douglas E Chandler
Journal:  J Mol Evol       Date:  2017-10-25       Impact factor: 2.395

5.  A PR-1-like protein of Fusarium oxysporum functions in virulence on mammalian hosts.

Authors:  Rafael C Prados-Rosales; Raquel Roldán-Rodríguez; Carolina Serena; Manuel S López-Berges; Josep Guarro; Álvaro Martínez-del-Pozo; Antonio Di Pietro
Journal:  J Biol Chem       Date:  2012-05-02       Impact factor: 5.157

6.  Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.

Authors:  Imke Müller; Frank Wischnewski; Klaus Pantel; Heidi Schwarzenbach
Journal:  BMC Cancer       Date:  2010-06-17       Impact factor: 4.430

7.  Inhibition of HIV-1 replication by small interfering RNAs directed against glioma pathogenesis related protein (GliPR) expression.

Authors:  Gianni Capalbo; Thea Müller-Kuller; Ursula Dietrich; Dieter Hoelzer; Oliver G Ottmann; Urban J Scheuring
Journal:  Retrovirology       Date:  2010-03-31       Impact factor: 4.602

8.  Co-expression of COX-2 and 5-LO in primary glioblastoma is associated with poor prognosis.

Authors:  Xingfu Wang; Yupeng Chen; Sheng Zhang; Lifeng Zhang; Xueyong Liu; Li Zhang; Xiaoling Li; Dayang Chen
Journal:  J Neurooncol       Date:  2015-09-03       Impact factor: 4.130

9.  Hypomethylation and aberrant expression of the glioma pathogenesis-related 1 gene in Wilms tumors.

Authors:  Laxmi Chilukamarri; Anne L Hancock; Sally Malik; Joanna Zabkiewicz; Jenny A Baker; Alexander Greenhough; Anthony R Dallosso; Tim Hui-Ming Huang; Brigitte Royer-Pokora; Keith W Brown; Karim Malik
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

10.  GRP78 is overexpressed in glioblastomas and regulates glioma cell growth and apoptosis.

Authors:  Hae Kyung Lee; Cunli Xiang; Simona Cazacu; Susan Finniss; Gila Kazimirsky; Nancy Lemke; Norman L Lehman; Sandra A Rempel; Tom Mikkelsen; Chaya Brodie
Journal:  Neuro Oncol       Date:  2008-04-10       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.